November/December 2015

High-Cost Medications: A Double-Edged Sword

January 07, 2016

The American Journal of Pharmacy Benefits

Although the focus in drug trends has primarily been on unit cost, it is time we look at the other factors involved, including value and quality of life.

New Challenges and Opportunities in Immunization Quality Metrics

January 07, 2016

The American Journal of Pharmacy Benefits

In the United States, adult immunization rates are substandard. Opportunities exist to improve these rates trough quality performance measurement, but not without challenges.

Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung Cancer

January 06, 2016

The American Journal of Pharmacy Benefits

A national community-level study of Medicare patients with advanced non-small cell lung cancer found that adding targeted therapy to chemotherapy regimens was not cost-effective.

Take 2: Revised Audit Protocols for Medicare Plans

January 06, 2016

The American Journal of Pharmacy Benefits

For Medicare plans, the 2015/2016 program audit protocol updates address many of the issues and questions raised with the previous protocols, but may result in additional challenges.